CDT Conduit Pharmaceuticals
- 0.138
- -0.002-1.36%
Conduit Pharmaceuticals News
424B3: Prospectus
EFFECT: Others
424B3: Prospectus
424B3: Prospectus
EFFECT: Others
Conduit Pharmaceuticals | 424B3: Prospectus
Conduit Pharmaceuticals | EFFECT: Others
Murphy Canyon Acquisition Corp | 8-A12B: Registration of a class of securities on a national securities exchange
Murphy Canyon Acquisition Corp | 424B3: Prospectus
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 424B3: Prospectus
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | EFFECT: Others
Murphy Canyon Acquisition Corp | 424B3: Prospectus
Murphy Canyon Acquisition Corp | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Murphy Canyon Acquisition Corp | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Analysis
Price Target
No Data
No Data